Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance

Celgene (NASDAQ: CELG) reported Q2 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.7 billion.

GUIDANCE:

Celgene sees FY2018 EPS of $8.70-$8.75, versus the consensus of $8.52. Celgene sees FY2018 revenue of $15 billion, versus the consensus of $14.93 billion.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance
• Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
• California Resources completes $63M acquisition of Crimson Midstream